Precision Oncology—The Quest for Evidence
The molecular characterization of patient tumors provides a rational and highly promising approach for guiding oncologists in treatment decision-making. Notwithstanding, genomic medicine still remains in its infancy, with innovators and early adopters continuing to carry a significant portion of the...
Main Authors: | Theodoros G. Soldatos, Sajo Kaduthanam, David B. Jackson |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-09-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/9/3/43 |
Similar Items
-
Understanding the Economic Value of Molecular Diagnostic Tests: Case Studies and Lessons Learned
by: Adrian Towse, et al.
Published: (2013-10-01) -
A path to precision in the ICU
by: David M. Maslove, et al.
Published: (2017-04-01) -
Personalised, Rational, Efficacy-Driven Cancer Drug Dosing via an Artificial Intelligence SystEm (PRECISE): A Protocol for the PRECISE CURATE.AI Pilot Clinical Trial
by: Benjamin Kye Jyn Tan, et al.
Published: (2021-04-01) -
Strategies to Integrate Genomic Medicine into Clinical Care: Evidence from the IGNITE Network
by: Nina R. Sperber, et al.
Published: (2021-07-01) -
Drug-diagnostics co-development in oncology
by: Richard eSimon
Published: (2013-12-01)